The world awaits anxiously for a vaccine to the COVID-19 virus, but what happens once we have it? Please join us for a discussion with senior business and government leaders that explores the logistical, manufacturing, and distribution challenges of delivering vaccines to 7.8 billion people – including ensuring a sufficient supply of hypodermic needles, keeping vaccines from spoiling, how to deliver the vaccine globally, and why pharmaceutical companies are mass producing vaccines that are still being developed. These are some of the topics that will be discussed during this Now + Next virtual event.